Technical Analysis for AKRX - Akorn, Inc.

Grade Last Price % Change Price Change
grade C 4.04 -5.39% -0.23
AKRX closed down 5.39 percent on Friday, May 24, 2019, on 46 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical AKRX trend table...

Date Alert Name Type % Chg

Older signals for AKRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Akorn, Inc. engages in the manufacture and marketing of diagnostic and therapeutic ophthalmic pharmaceuticals products, hospital drugs, and injectable pharmaceuticals in the United States and internationally. It offers products in various specialty areas, including ophthalmology, antidotes, anti-infectives, pain management, anesthesia, and vaccines. The company's Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, angiography dyes, and others primarily for use in the office setting. This segment also offers therapeutic products, such as antibiotics, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers; and non-pharmaceutical products, which include various artificial tear solutions, preservative-free lubricating ointments, and eyelid cleansers. In addition, the Ophthalmic segment provides a line of over-the-counter dry eye and other eye health products principally under the TheraTears brand name through a chain drug stores and big box retailers, as well as directly to optometrists, ophthalmologists, and other eye care practitioners and clinics. Its Hospital Drugs & Injectables segment provides a line of hospital drug and injectable pharmaceutical products comprising antidotes, anti-infectives, controlled substances for pain management and anesthesia, and other pharmaceutical products to hospitals through the wholesale distribution channel. The company's Contract Services segment manufactures ophthalmic and injectable pharmaceutical products for third party pharmaceutical customers based on their specifications. It serves physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains, and other pharmaceutical companies. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois.
Medicine Health Pharmaceutical Pharmacy Pharmaceutical Products Pharmaceutical Industry In China Pain Management Antibiotics Cnx Nifty Glaucoma Therapeutic Products Ophthalmology Anti Infectives Optometry Eye Health Products Injectable Pharmaceuticals Non Pharmaceutical Products Ophthalmic
Is AKRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 19.65
52 Week Low 2.64
Average Volume 2,682,172
200-Day Moving Average 6.5845
50-Day Moving Average 3.4838
20-Day Moving Average 3.8255
10-Day Moving Average 4.238
Average True Range 0.314
ADX 35.14
+DI 30.9914
-DI 15.9961
Chandelier Exit (Long, 3 ATRs ) 3.898
Chandelier Exit (Short, 3 ATRs ) 3.582
Upper Bollinger Band 5.19
Lower Bollinger Band 2.461
Percent B (%b) 0.58
BandWidth 71.33708
MACD Line 0.2621
MACD Signal Line 0.2536
MACD Histogram 0.0085
Fundamentals Value
Market Cap 504.38 Million
Num Shares 125 Million
EPS 0.99
Price-to-Earnings (P/E) Ratio 4.08
Price-to-Sales 4.02
Price-to-Book 4.63
PEG Ratio -4.09
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.51
Resistance 3 (R3) 4.55 4.45 4.43
Resistance 2 (R2) 4.45 4.33 4.42 4.40
Resistance 1 (R1) 4.24 4.26 4.19 4.20 4.38
Pivot Point 4.14 4.14 4.11 4.11 4.14
Support 1 (S1) 3.93 4.02 3.88 3.89 3.70
Support 2 (S2) 3.83 3.95 3.80 3.68
Support 3 (S3) 3.62 3.83 3.65
Support 4 (S4) 3.58